Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (221-230 of 682) with videos related to

Pageof 69
Sort By:
Antimicrobial Agents and Chemotherapy|March 16, 2011
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimensJason A Roberts, Fabio Silvio Taccone, Andrew A Udy, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill PatientsMieke Carlier, Jason A Roberts, Veronique Stove, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 3, 2022
Therapeutic Drug Monitoring and Prolonged Infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa Infections: An Observational StudyMaría Eugenia Navarrete-Rouco, Sònia Luque, Luisa Sorlí, et al.
International Journal of Antimicrobial Agents|August 28, 2024
The impact of extracorporeal support on antimicrobial pharmacokinetics in critically ill neonatal and paediatric patients: A systematic reviewMichele L Cree, Mohd Hafiz Abdul-Aziz, Luregn J Schlapbach, et al.
Chemotherapy|January 16, 2020
Amoxicillin-Clavulanate Dosing in the Intensive Care Unit: The Additive Effect of Renal Replacement Therapy in a Patient with Normal Kidney FunctionDagan Osborne Lonsdale, Jeffrey Lipman, Amelia Livermore, et al.
Expert Review of Clinical Pharmacology|March 29, 2016
Therapeutic drug monitoring of anti-infective agents in critically ill patientsNynke G L Jager, Reinier M van Hest, Jeffrey Lipman, et al.
Antibiotics (Basel, Switzerland)|November 11, 2022
Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates in a Hollow-Fibre Infection ModelSazlyna Mohd Sazlly Lim, Aaron Heffernan, Saiyuri Naicker, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Current and Emerging Treatment Options for Multidrug Resistant <i>Escherichia coli</i> Urosepsis: A ReviewMikaela M Walker, Jason A Roberts, Benjamin A Rogers, et al.
Pharmacotherapy|December 26, 2022
In silico evaluation of a beta-lactam dosing guideline among adults with serious infectionsPaul Williams, Menino Osbert Cotta, Mohd H Abdul-Aziz, et al.
Communicable Diseases Intelligence Quarterly Report|January 2, 2010
Annual report of the Australian National Poliovirus Reference Laboratory, 2008Jason A Roberts, Kristina A Grant, Yeon Kyung Yoon, et al.
Pageof 69

Showing results (221-230 of 682) with videos related to

Sort By:
Pageof 69
Antimicrobial Agents and Chemotherapy|March 16, 2011
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimensJason A Roberts, Fabio Silvio Taccone, Andrew A Udy, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill PatientsMieke Carlier, Jason A Roberts, Veronique Stove, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 3, 2022
Therapeutic Drug Monitoring and Prolonged Infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa Infections: An Observational StudyMaría Eugenia Navarrete-Rouco, Sònia Luque, Luisa Sorlí, et al.
International Journal of Antimicrobial Agents|August 28, 2024
The impact of extracorporeal support on antimicrobial pharmacokinetics in critically ill neonatal and paediatric patients: A systematic reviewMichele L Cree, Mohd Hafiz Abdul-Aziz, Luregn J Schlapbach, et al.
Chemotherapy|January 16, 2020
Amoxicillin-Clavulanate Dosing in the Intensive Care Unit: The Additive Effect of Renal Replacement Therapy in a Patient with Normal Kidney FunctionDagan Osborne Lonsdale, Jeffrey Lipman, Amelia Livermore, et al.
Expert Review of Clinical Pharmacology|March 29, 2016
Therapeutic drug monitoring of anti-infective agents in critically ill patientsNynke G L Jager, Reinier M van Hest, Jeffrey Lipman, et al.
Antibiotics (Basel, Switzerland)|November 11, 2022
Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates in a Hollow-Fibre Infection ModelSazlyna Mohd Sazlly Lim, Aaron Heffernan, Saiyuri Naicker, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Current and Emerging Treatment Options for Multidrug Resistant <i>Escherichia coli</i> Urosepsis: A ReviewMikaela M Walker, Jason A Roberts, Benjamin A Rogers, et al.
Pharmacotherapy|December 26, 2022
In silico evaluation of a beta-lactam dosing guideline among adults with serious infectionsPaul Williams, Menino Osbert Cotta, Mohd H Abdul-Aziz, et al.
Communicable Diseases Intelligence Quarterly Report|January 2, 2010
Annual report of the Australian National Poliovirus Reference Laboratory, 2008Jason A Roberts, Kristina A Grant, Yeon Kyung Yoon, et al.
Pageof 69